I. Glenn Cohen, Fordham Law Review
This Essay, Part of a Symposium on Drug Law for the 21st Century, proceeds as follow. Part I briefly describes how vociferous this debate has become among advocates for the medical use of psychedelics. Part II discusses why this choice matters, legally and ethically. This includes a discussion of the potential FDA approval process for psychedelics, implications for cost and access (including insurance), what it might mean for professionalization and licensure, and the future of supported adult use frameworks we have seen in states like Oregon.